Device / Technology News

RSS

Medical device components that inhibit bacterial growth

Medical device components that inhibit bacterial growth

Vyon® porous plastics from Porvair Sciences are the perfect material for filtration applications in the healthcare and medical device market.

From Porvair Sciences Limited 14 Sep 2022

Fast and simple picking of whole tissue samples from storage

Fast and simple picking of whole tissue samples from storage

Ziath announce the launch of the Mohawk 48 tube selector and picker. Designed to select and pick wide, heavy, or tall tubes - this new system is perfect for retrieving individual whole tissue samples from storage.

12 Sep 2022

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes

From PhoreMost 6 Sep 2022

Reservoir ensures sustainable use of reagents

Reservoir ensures sustainable use of reagents

Manufactured to the ANSI/SLAS standard, the range of reagent reservoirs from Porvair Sciences are designed for simple integration into any automated liquid handling system.

From Porvair Sciences Limited 24 Aug 2022

Engineers develop the world's smallest EEG caps for mini brains

Engineers develop the world's smallest EEG caps for mini brains

It could be the world's tiniest EEG electrode cap, created to measure activity in a brain model the size of a pen dot. Its designers expect the device to lead to better understanding of neural disorders and how potentially dangerous chemicals affect the brain.

18 Aug 2022

New type of chip could lead to earlier and more targeted treatment for cancer

New type of chip could lead to earlier and more targeted treatment for cancer

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible to track.

17 Aug 2022

Healthcare super fund HESTA directly invests in Inventia Life Science

Healthcare super fund HESTA directly invests in Inventia Life Science

Inventia Life Science has today announced that HESTA have invested AU$4.4 million in Inventia Life Science.

From Inventia Life Science 16 Aug 2022

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform

From Inventia Life Science 16 Aug 2022

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science announced that its RASTRUM™ 3D cell culture platform has won the ANSTO Eureka Prize for Innovative Use of Technology at the 2021 Australian Museum Eureka Prizes.

From Inventia Life Science 16 Aug 2022

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and Xylyx Bio today announced their strategic partnership following promising results developing more realistic, scalable, and reproducible 3D cell cultures for drug discovery and biomedical research.

From Inventia Life Science 16 Aug 2022

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

As a result of this partnership, Inventia Life Science will now offer BioLamina’s extensive range of Biolaminin® products incorporated into the pre-validated library of RASTRUM™ Matrices, recapitulating the key motifs found in the native tissue of various cell types.

From Inventia Life Science 16 Aug 2022

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ has taken out the top prize in the Experimental category. RASTRUM™ prints human cells into living tissue models to supercharge research into cancer and other diseases using revolutionary drop-on-demand technology.

From Inventia Life Science 16 Aug 2022

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science, a leader in automated generation of complex 3D cell models, and PhenoVista Biosciences, a top provider of custom imaging-based phenotypic assay services, have entered into a partnership to deliver high-content cell-based assay services for drug discovery.

From Inventia Life Science 16 Aug 2022

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform.

From Evonetix 16 Aug 2022

UCLA researchers receive NIH award to develop next-generation versions of miniature microscope

UCLA researchers receive NIH award to develop next-generation versions of miniature microscope

The UCLA creators of a miniature microscope that can be mounted on the heads of lab animals to provide an invaluable view into the brain's inner workings have received a $4 million grant from the National Institutes of Health to develop next-generation versions of their "miniscope."

9 Aug 2022

Study proposes a systematic engineering approach of optimizing protein-fortified food inks

Study proposes a systematic engineering approach of optimizing protein-fortified food inks

As the global population continues to age and grow, the demand for protein-rich food is also expected to increase concurrently.

8 Aug 2022

Optimised microplate for cannabis sample processing

Optimised microplate for cannabis sample processing

Porvair Sciences has developed a 2 ml 96-well microplate whose design is optimised for labs processing cannabis samples for analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

From Porvair Sciences Limited 29 Jul 2022

Applying AI technology to boost Florida’s ailing citrus industry

Applying AI technology to boost Florida’s ailing citrus industry

As news broke that Florida's citrus industry ended this year's growing season with its lowest production in eight decades, an unlikely union has formed between two University of Florida startup companies to help reverse the trend.

25 Jul 2022

Researchers produce a molecular electric motor using the DNA origami method

Researchers produce a molecular electric motor using the DNA origami method

A research team led by the Technical University of Munich (TUM) has succeeded for the first time in producing a molecular electric motor using the DNA origami method.

22 Jul 2022

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

22 Jul 2022

Previous
1
...
11
12
13
14
15
16
17
...
21
Next

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.